The launch of a study with clinical oversight from Washington State University marks the commencement of this partnership between SPD and Fisher Wallace

The investment comes at a time of growth for Fisher Wallace with the launch of an equity crowdfunding campaign through StartEngine

By joining the ranks of Y Combinator's Winter 22 batch, Actipulse Neuroscience is ready to accelerate the development of its clinical pipeline, most notably the start of their FDA pivotal trial to bring their proprietary non-invasive brain neuromodulation technology to the home of patients diagnosed with Major Depressive Disorder.

This trial marks the first step taken by Actipulse Neuroscience to use a new method of neuromodulation to stop or slow Alzheimer's disease, an issue that fails to be solved by anything currently available on the market

Neuroscience R&D Technologies Conference to be held in Barcelona, Spain on 3 - 4 December 2015 will gather global neuroscience experts to discuss developments in brain imaging, animal models, neurogames, neuroinformatics and neuromodulation among others.

Soterix Medical Inc. announces a multidisciplinary study based at the University of Illinois Beckman Institute to determine if High-Definition tDCS (HD-tDCS) in conjunction with other interventions improves adaptive reasoning and fluid intelligence.